TECHNEGAS KIT (technetium tc-99m labeled carbon)
Technegas is an inhalation aerosol used for adults and children aged six years and older to help visualize how air flows through the lungs. It helps clinicians evaluate patients for potential pulmonary embolisms when used alongside perfusion imaging. This diagnostic tool provides a way to see pulmonary ventilation to assist in respiratory assessments.
How TECHNEGAS KIT Works
This aerosol works by depositing radioactive carbon particles onto the lining of the small airways and air sacs within the lungs. The distribution of these particles is driven by the lungs' natural airflow rather than specific chemical receptors. This allows the system to create a map of where air is reaching in the pulmonary system.
Details
- Status
- Prescription
- First Approved
- 2023-09-29
- Patent Cliff
- 2031
- Routes
- INHALATION
- Dosage Forms
- AEROSOL
TECHNEGAS KIT Approval History
What TECHNEGAS KIT Treats
1 indicationsTECHNEGAS KIT is approved for 1 conditions since its original approval in 2023. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Pulmonary Embolism
TECHNEGAS KIT Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
What's emerging in TECHNEGAS KIT's indications
See all emerging drugs →Phase 3 candidates targeting molecules with no FDA-approved drug, in indications TECHNEGAS KIT treats. First-in-class if their pivotal trials read out positive.
Drugs Similar to TECHNEGAS KIT
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
TECHNEGAS KIT FDA Label Details
Indications & Usage
FDA Label (PDF)TECHNEGAS KIT is indicated for the treatment of Pulmonary Embolism.
TECHNEGAS KIT Patents & Exclusivity
Patents (1 active)
Exclusivity
Pro Intelligence Preview
Deep insights for TECHNEGAS KIT
Revenue Insights
- • Quarterly revenue tracking
- • Historical trend analysis
Patent Timeline
- • Cliff: 2031
- • 1 active patents
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • 20 similar drugs
- • Same target/indication analysis
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.